Remdesivir-loaded bis-MPA hyperbranched dendritic nanocarriers for pulmonary delivery-Reference-Cited by-同舟云学术

Remdesivir-loaded bis-MPA hyperbranched dendritic nanocarriers for pulmonary delivery

Published:2022-09 Issue: Volume:75 Page:103625
ISSN:1773-2247
Container-title:Journal of Drug Delivery Science and Technology
language:en
Short-container-title:Journal of Drug Delivery Science and Technology

Author:

Halevas Eleftherios^ORCID,Mavroidi Barbara^ORCID,Kokotidou Chrysoula^ORCID,Moschona Alexandra,Sagnou Marina^ORCID,Mitraki Anna,Litsardakis George^ORCID,Pelecanou Maria^ORCID

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference54 articles.

1. Remdesivir: from Ebola to COVID-19;Santoro;Biochem. Biophys. Res. Commun.,2021

2. Remdesivir: a Review of its discovery and development leading to emergency use authorization for treatment of COVID-19;Eastman;ACS Cent. Sci.,2020

3. Therapeutic strategies to fight COVID‐19: which is the status artis?;Scavone;Br. J. Pharmacol.,2021

4. Remdesivir for treatment of COVID-19: combination of pulmonary and IV administration may offer additional benefit;Sun;AAPS J.,2020

5. Remdesivir for treatment of COVID-19; an updated systematic review and meta-analysis;Rezagholizadeh;Eur. J. Pharmacol.,2021

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Opportunities and Challenges for Inhalable Nanomedicine Formulations in Respiratory Diseases: A Review;International Journal of Nanomedicine;2024-02

2. Remdesivir-Loaded Nanoliposomes Stabilized by Chitosan/Hyaluronic Acid Film with a Potential Application in the Treatment of Coronavirus Infection;Neurology International;2023-10-30

3. Chitosan-Based Nanocarriers for Delivery of Remdesivir;Scientia Pharmaceutica;2023-08-09

4. Remdesivir nanosuspension for potential nasal drug delivery: determination of pro-inflammatory interleukin IL-4 mRNA expression and industrial scale-up strategy;Journal of Nanoparticle Research;2023-06-19

5. Recent Advances in Inhaled Nanoformulations of Vaccines and Therapeutics Targeting Respiratory Viral Infections;Pharmaceutical Research;2023-04-25